Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dyne Therapeutics, Inc.

12.56
+1.1510.08%
Pre-market: 13.540.9800+7.80%04:02 EDT
Volume:4.78M
Turnover:60.19M
Market Cap:1.43B
PE:-3.47
High:13.03
Open:12.12
Low:11.64
Close:11.41
Loading ...
May 06, 2021

Major Issues Report

8-K - Current report
Mar 04, 2021

Major Issues Report

8-K - Current report
Mar 04, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 04, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 19, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jan 19, 2021

Major Issues Report

8-K - Current report
Dec 09, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 01, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Sep 28, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 21, 2020

Major Issues Report

8-K - Current report